Barriers and facilitators to the use of medications for opioid use disorder: a rapid review

K Mackey, S Veazie, J Anderson, D Bourne… - Journal of general …, 2020 - Springer
Background Despite evidence that medications to treat opioid use disorder (OUD) are
effective, most people who could benefit from this treatment do not receive it. This rapid …

[HTML][HTML] Improving access to evidence-based medical treatment for opioid use disorder: strategies to address key barriers within the treatment system

BK Madras, NJ Ahmad, J Wen, JS Sharfstein - NAM perspectives, 2020 - ncbi.nlm.nih.gov
Even though evidence-based treatment for opioid use disorders (OUD) is effective, almost
four in five Americans with OUD do not receive any form of treatment. The gap in access to …

Stigma as a fundamental hindrance to the United States opioid overdose crisis response

AC Tsai, MV Kiang, ML Barnett, L Beletsky… - PLoS …, 2019 - journals.plos.org
Stigma as a fundamental hindrance to the United States opioid overdose crisis response |
PLOS Medicine Skip to main content Advertisement PLOS Medicine Browse Current Issue …

[HTML][HTML] Medication-Assisted Treatment for Opioid Use Disorder

National Academies of Sciences, Engineering, and … - 2018 - ncbi.nlm.nih.gov
On October 30 and 31, 2018, the Committee on Medication-Assisted Treatment (MAT) for
Opioid Use Disorder (OUD) held a 1.5-day workshop in Washington, DC. To support the …

Tackling the overdose crisis: the role of safe supply

A Ivsins, J Boyd, L Beletsky, R McNeil - International Journal of Drug Policy, 2020 - Elsevier
North America is experiencing an unprecedented overdose crisis driven by the proliferation
of fentanyl and its analogues in the illicit drug supply. In 2018 there were 67,367 drug …

A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder

K Cioe, BE Biondi, R Easly, A Simard, X Zheng… - Journal of Substance …, 2020 - Elsevier
Background The opioid epidemic is a public health crisis. Medications for opioid use
disorder (MOUD) include: 1) buprenorphine, 2) methadone, and 3) extended-release …

Survey of barriers and facilitators to prescribing buprenorphine and clinician perceptions on the Drug Addiction Treatment Act of 2000 waiver

HJ Lanham, J Papac, DI Olmos… - JAMA network …, 2022 - jamanetwork.com
Importance As opioid-related deaths continue to climb, methods to reduce barriers to
prescribing buprenorphine for individuals with opioid use disorder (OUD) are needed …

In rural areas, buprenorphine waiver adoption since 2017 driven by nurse practitioners and physician assistants

ML Barnett, D Lee, RG Frank - Health Affairs, 2019 - healthaffairs.org
Few patients with opioid use disorder receive medication for addiction treatment. In 2017 the
Comprehensive Addiction and Recovery Act enabled nurse practitioners (NPs) and …

“You're not supposed to be on it forever”: Medications to treat opioid use disorder (MOUD) related stigma among drug treatment providers and people who use opioids

J Dickson-Gomez, A Spector, M Weeks… - Substance Abuse …, 2022 - journals.sagepub.com
Opioid use disorder (OUD) through prescription opioid misuse, heroin, and illicitly
manufactured fentanyl use has increased dramatically in the past 20 years. Medications to …

Physician Reluctance to Intervene in Addiction: A Systematic Review

MC von Klimo, L Nolan, M Corbin, L Farinelli… - JAMA Network …, 2024 - jamanetwork.com
Importance The overdose epidemic continues in the US, with 107 941 overdose deaths in
2022 and countless lives affected by the addiction crisis. Although widespread efforts to train …